▸ The 2025 CGU Biodesign Workshop drew enthusiastic participation from physicians, faculty members, and students from Chang Gung University, Chang Gung Memorial Hospital, National Taiwan University, and Chung Yuan Christian University.
At the core of Biodesign is a focus on identifying unmet clinical needs directly from real-world medical settings and patient experiences. Using a structured innovation process, Biodesign systematically uncovers unresolved clinical problems and seeks the most appropriate technological solutions. For this workshop, Professor Peng-Ting Chen from National Cheng Kung University—also a member of the Stanford Biodesign Global Faculty—and her team were specially invited as instructors. The course content was tailored to Taiwan's healthcare environment and covered key topics such as clinical needs assessment and exploration, ideation and concept development, market feasibility analysis, risk assessment, and strategic planning. Through group-based hands-on activities and brainstorming sessions, participants were guided to design promising medical technologies or products that have the potential to address real clinical pain points.
▸ Professor Peng-Ting Chen led the team members in conducting clinical needs assessment and exploration.
Chang Gung University is actively implementing the National Science and Technology Council’s SPARK Program, a talent cultivation initiative aimed at accelerating translational development in biomedicine and medical devices. The university is dedicated to nurturing talent to support teams in developing new drugs and medical technologies, while also guiding them toward potential paths such as startup formation, technology transfer, or integration into large-scale projects. Within this program, Biodesign-based training serves as a critical foundation. Introducing this mindset early in the development of new drugs or medical devices can significantly increase the chances of successful technology advancement and commercialization.
▸ The Biodesign Workshop intentionally grouped participants from diverse backgrounds, fostering cross-disciplinary brainstorming and guided mentorship to collaboratively design innovative products that address clinical needs while demonstrating market feasibility.
In the future, Chang Gung University will continue to advance the research and development of new drugs and medical devices by actively integrating internal resources, the Chang Gung healthcare system, and the innovation capacities of universities in the Taoyuan region. The university is committed not only to the commercialization of technologies but also to cultivating entrepreneurial talent with cross-disciplinary integration capabilities, thereby expanding the impact of the biomedical innovation ecosystem.